Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 1, Issue 8 (2012)

Diabetic Retinopathy- Symptoms, Causes, Risk Factors and Treatment

Author(s):
K. P. Sampath Kumar*, Debjit Bhowmik, G.Harish, S.Duraivel, B.Pragathi kumar
Abstract:
Diabetic retinopathy is a condition occurring in persons with diabetes, which causes progressive damage to the retina, the light sensitive lining at the back of the eye. It is a serious sight-threatening complication of diabetes. Diabetes is a disease that interferes with the body's ability to use and store sugar, which can cause many health problems. Too much sugar in the blood can cause damage throughout the body, including the eyes. Over time, diabetes affects the circulatory system of the retina. Diabetic retinopathy is the result of damage caused by diabetes to the small blood vessels located in the retina. Blood vessels damaged from diabetic retinopathy can cause vision loss: Fluid can leak into the macula, the area of the retina which is responsible for clear central vision. Although small, the macula is the part of the retina that allows us to see colors and fine detail. The fluid causes the macula to swell, resulting in blurred vision. In an attempt to improve blood circulation in the retina, new blood vessels may form on its surface. These fragile, abnormal blood vessels can leak blood into the back of the eye and block vision. Diabetic retinopathy is the result of damage to the tiny blood vessels that nourish the retina. They leak blood and other fluids that cause swelling of retinal tissue and clouding of vision. The condition usually affects both eyes. The longer a person has diabetes, the more likely they will develop diabetic retinopathy. If left untreated, diabetic retinopathy can cause blindness.
Pages: 07-13  |  2709 Views  830 Downloads


The Pharma Innovation Journal
How to cite this article:
K. P. Sampath Kumar*, Debjit Bhowmik, G.Harish, S.Duraivel, B.Pragathi kumar. Diabetic Retinopathy- Symptoms, Causes, Risk Factors and Treatment. Pharma Innovation 2012;1(8):07-13.

Call for book chapter